Never Too Late: if you missed The IPKat last week By Magdaleen Jooste on Sunday, March 07, 2021 #IPKat #NeverTooLate actavis assignment Book review copyright cyberlockers FRAND Magdaleen Jooste +
Illumina v MGI Part 2: Has the UK lost its way on the doctrine of equivalents? By Dr Rose Hughes on Saturday, February 27, 2021 actavis doctrine of equivalence patents Rose Hughes +
BREAKING: Supreme Court confirms no hard line on inventive step test in finding Cialis dosage patent obvious By Dr Rose Hughes on Wednesday, March 27, 2019 actavis Court of Appeal dosage dosage regime patents formulation patents obviousness patents priority reasonable expectation of success Second medical use +
Event Report: UCL IBIL - Pregabalin: Where stand plausibility and Swiss-form claims? PART 1 By Dr Rose Hughes on Wednesday, January 09, 2019 actavis ibil lyrica patents plausibility Second medical use swiss form claim Warner-Lambert +
An IPSOC Q&A with Mr Justice Birss By Rosie Burbidge on Monday, May 14, 2018 actavis Anderson bees Birss brand eli lilly Enron FRAND Image rights IPEC IPSoc own name defence patent procedure shorter trials scheme trade marks +
Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle By Eleonora Rosati on Thursday, February 22, 2018 abuse of process actavis construction Eleonora Rosati indirect infringement lyrica mylan Patent amendment plausibility Pregabalin Second medical use swiss form claim uk supreme court +
French Supreme Court in Finasteride second-medical use litigation acknowledges patentability of dosage regime claims By Annsley Merelle Ward on Thursday, January 11, 2018 actavis AmeriKat dosage dosage regime patents french patent law French supreme court MSD Second medical use Teva +
The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious By Annsley Merelle Ward on Sunday, November 05, 2017 actavis AmeriKat burden of proof Court of Appeal dosage dosage regime patents formulation patents obviousness priority reasonable expectation of success Teva +